Article
Genetic Misdiagnoses and the Potential for Health Disparities.
The New England journal of medicine - 18 Aug 2016
Manrai Arjun K, Funke Birgit H, Rehm Heidi L, Olesen Morten S, Maron Bradley A, Szolovits Peter, Margulies David M, Loscalzo Joseph, Kohane Isaac S
Abstract excerpt
BACKGROUND: For more than a decade, risk stratification for hypertrophic cardiomyopathy has been enhanced by targeted genetic testing. Using sequencing results, clinicians routinely assess the risk of hypertrophic cardiomyopathy in a patient's relatives and diagnose the condition in patients who have ambiguous clinical presentations. However, the benefits of genetic testing come with the risk that variants may be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
